1-2 of 2
Rinske Boersma
Close
Sort by
Journal Articles

Distinct peripheral T-cell and NK-cell profiles in HGBL- MYC/BCL2 vs patients with DLBCL NOS

A. Vera de Jonge, Carolien Duetz, Wassilis S. C. Bruins, Charlotte L. B. M. Korst, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Marcel Nijland, Marjolein W. M. van der Poel, Koen de Heer, Clara P. W. Klerk, Leonie Strobbe, Margriet Oosterveld, Rinske Boersma, Harry R. Koene, Margaretha G. M. Roemer, Erik van Werkhoven, Martine E. D. Chamuleau, Tuna Mutis
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1094–1104.
https://doi.org/10.1182/bloodadvances.2023011687
Published: 2024
Includes: Supplemental data
Journal Articles

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Clinical Trials & Observations
Gerwin Huls, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Isabelle van Zeventer, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4267–4277.
https://doi.org/10.1182/bloodadvances.2020002846
Published: 2020
Includes: Supplemental data